Diabetes Complications: Clinical Trials

231 trials for Diabetes Complications, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

142 completed, 38 unknown, 17 terminated, 12 recruiting. 231 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4231Completed 142, Unknown 38, Terminated 17, Recruiting 12, Not yet recruiting 10, Withdrawn 7, Active not recruiting 3, Enrolling by invitation 2

Follow Diabetes Complications: new trials by email Literature Review of Diabetes Complications trials Research Report on Diabetes Complications

Trials (filtered) newest first · largest first

All 231 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD
Naoxintong Capsule, Placebo - Diabetic Nephropathy
Phase 4Not yet recruitingChen Xiangmei4102027-03-012026-07-13
Efficacy of Topical Lidocaine Gel vs. Oral Duloxetine for Painful Diabetic Peripheral Neuropathy
Topical Lidocaine 2% Gel, Duloxetine (60 MG) - Painful Diabetic Neuropathy (PDN), Diabetic Neuropathies
Phase 4Not yet recruitingWah Medical college , POF hospital802026-12-012026-09-02
Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy
Cognitive Behavioral Therapy (CBT), Oral Medication, Topical Medication - Painful Diabetic Neuropathy (PDN), Diabetic Nephropathies
Phase 4Not yet recruitingUniversity of Michigan6002026-11-012026-10-21
Seltoplasmid Plus Revascularization for Diabetic Infrapopliteal Chronic Limb-Threatening Ischemia
Lower-Extremity Revascularization, Donaperminogene Seltoplasmid - Chronic Limb-Threatening Ischemia, Diabetic Foot Ulcer
Phase 4Not yet recruitingFirst Affiliated Hospital of Wenzhou Medical University1802026-10-202026-09-18
Iopidine to Decrease Intraocular Pressure Rise After Injections
Apraclonidine 1.0% ophthalmic solution - Macular Degeneration, Diabetic Retinopathy
Phase 4Not yet recruitingRetina Consultants of Delmarva1202026-10-012026-10-23
Role of Finerenone in African American Veterans With Diabetic Kidney Disease
Finerenone 10 MG, Empagliflozin 10 MG - Diabetic Kidney Disease
Phase 4Not yet recruitingWashington D.C. Veterans Affairs Medical Center302026-10-012026-08-21
Randomized, Controlled Study to Investigate the 12-month Efficacy and Safety of Resveratrol Vitamin Supplements in Patients With Non-proliferative Diabetic Retinopathy Without Center Involved Diabetic Macular Edema (REVOLUTION Study)
Resveratrol-Containing Vitamin Supplement - Diabetic Retinopathy, Non Proliferative Diabetic Retinopathy
Phase 4CompletedUniversity of Athens1002026-09-302026-10-09
Continuous Delivery of Ranibizumab Via the Port Delivery System for Proliferative Diabetic Retinopathy-related Vitreous Hemorrhage With Pars Plana Vitrectomy and Limited PRP.
PDS Implant filled with 100 mg/mL Ranibizumab, Ranibizumab - Proliferative Diabetic Retinopathy, Diabetic Retinopathy
Phase 4Not yet recruitingSoutheast Retina Center, Georgia202026-09-012026-10-13
Patient Comfort Following Intravitreal Injections Using Iheezo Versus Standard Anesthesia
Iheezo, Lidocaine pledget - Macular Degeneration, Diabetic Retinopathy
Phase 4CompletedRetina Consultants of Delmarva502026-05-202026-08-21
Corticosteroid for Diabetic Macular Edema (DME) Study
Intravitreal dexamethasone implant - Diabetic Macular Edema (DME), Diabetic Retinopathy
Phase 4RecruitingVanderbilt University Medical Center202026-04-072026-09-28
Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study
Finerenone, Spironolactone (drug) - Heart Failure, Diabetic Kidney Disease
Phase 4Not yet recruitingHospital de Messejana Dr. Carlos Alberto Studart Gomes602026-04-012026-05-13
Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections
Chloroprocaine Ophthalmic Gel 3% (IHEEZO), Sham Subconjunctival Injection, Proparacaine Hydrochloride Ophthalmic Solution 0.5% - Diabetic Macular Edema (DME), Age-Related Macular Degeneration (AMD)
Phase 4Enrolling by invitationHarrow Inc2362026-03-312026-04-07
To Evaluate the Efficacy and Safety of N-acetyl Cysteine Administration in Patients With Diabetic Retinopathy
N Acetyl cysteine, 1200mg (high dose) - Diabetic Retinopathy (DR)
Phase 4RecruitingAin Shams University762026-01-102026-06-09
Comparing Single Versus Multiple Anti-VEGF Injections in Diabetic Patients Undergoing Cataract Surgery
Aflibercept (Eylea) - Diabetic Retinopathy (DR), Diabetic Macular Edema (DME)
Phase 4Not yet recruitingAhmad Zeeshan Jamil1662026-01-012025-12-24
A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL
DermaBind TL - Diabetic Foot Ulcer (DFU), Venous Leg Ulcer (VLU)
Phase 4CompletedHealthTech Wound Care1502025-12-102026-10-30
ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases
ACE Reno - Hypertensive Nephropathy, Auto Immune Disorders
Phase 4RecruitingAce Cells Lab Limited3002025-09-202025-09-23
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
XWRAP - Diabetic Foot, Foot Ulcer
Phase 4RecruitingApplied Biologics, LLC602025-08-262026-02-11
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.
Amnio-Maxx® Dual Layer Amnion Patch, Standard of Care (Investigator Choice) - Diabetic Foot Ulcer (DFU), Amnio-Maxx
Phase 4RecruitingRoyal Biologics2482025-08-142025-10-07
Intraosseous Versus Intravenous Vancomycin in Below-Knee Amputation for Ischemic Diabetic Foot
Intraosseous Vancomycin, Intravenous Vancomycin - Diabetic Foot Disease, Diabetic Foot Infection
Phase 4CompletedBaşakşehir Çam & Sakura City Hospital402025-08-062026-07-10
Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
Standard of Care DFU, Tri-Membrane Wrap™ DFU, Membrane Wrap™ DFU - Diabetic Foot, DFU
Phase 4RecruitingBioLab Holdings6502025-07-152025-07-28

Showing 20 of 231. Sign in to see all of them.

Narrower conditions

Diabetic Nephropathies (65)  ·  Diabetic Foot (55)  ·  Diabetic Retinopathy (52)  ·  Diabetic Neuropathies (43)  ·  Diabetes Mellitus (38)  ·  Diabetes Mellitus, Type 2 (37)  ·  Diabetes Mellitus, Type 1 (13)  ·  Albuminuria (9)  ·  Renal Insufficiency, Chronic (9)  ·  Hypertension (8)  ·  Diabetic Ketoacidosis (7)  ·  Macular Edema (7)  ·  Varicose Ulcer (7)  ·  Foot Ulcer (6)

Broader conditions

Endocrine System Diseases (231)  ·  Diabetes Mellitus (193)  ·  Cardiovascular Diseases (121)  ·  Vascular Diseases (118)  ·  Diabetic Angiopathies (107)  ·  Metabolic Diseases (80)  ·  Nutritional and Metabolic Diseases (80)  ·  Glucose Metabolism Disorders (73)  ·  Female Urogenital Diseases and Pregnancy Complications (71)  ·  Urogenital Diseases (71)  ·  Female Urogenital Diseases (70)  ·  Male Urogenital Diseases (70)  ·  Urologic Diseases (70)  ·  Kidney Diseases (64)

Interventions

Ranibizumab (10)  ·  Duloxetine Hydrochloride (8)  ·  Standard of Care (8)  ·  aflibercept (8)  ·  Gabapentin (7)  ·  Bevacizumab (6)  ·  Calcium Dobesilate (6)  ·  Collagenases (6)  ·  Pregabalin (6)  ·  Valsartan (6)  ·  empagliflozin (6)  ·  Insulin Glargine (5)  ·  Losartan (5)  ·  Sodium Chloride (5)  ·  dapagliflozin (5)

Sponsors

Healthpoint (8)  ·  Amsterdam UMC, location VUmc (5)  ·  Boehringer Ingelheim (4)  ·  Novartis Pharmaceuticals (4)  ·  Osiris Therapeutics (4)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (4)  ·  Steno Diabetes Center Copenhagen (4)  ·  University of Aarhus (4)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  Cairo University (3)  ·  Eli Lilly and Company (3)  ·  Novartis (3)  ·  Peter Rossing (3)  ·  Smith & Nephew, Inc. (3)  ·  University Medical Center Groningen (3)

Countries

United States (80)  ·  China (19)  ·  Denmark (15)  ·  Netherlands (12)  ·  Brazil (10)  ·  Egypt (9)  ·  South Korea (9)  ·  Germany (8)  ·  Italy (8)  ·  United Kingdom (8)  ·  Canada (7)  ·  France (7)  ·  Australia (5)  ·  Mexico (5)  ·  Switzerland (4)

Top investigators

Herbert B Slade, MD (6)  ·  Ahmed A Abdel-Kader, MD, PhD (2)  ·  Ahmed A Mohalhal, MD, PhD (2)  ·  Ayman G Elnahry, MD, PhD (2)  ·  Francisco Garcia-Rio, MD (2)  ·  Peter Rossing, MD (2)  ·  Aaron I Vinik, MD, PhD (1)  ·  Ahlem Trifi (1)  ·  Alejandro E Macias, MD (1)  ·  Alireza Esteghamati, MD (1)

Results publications

PMID 38682786, PMID 35224730, PMID 27611736, PMID 30084288, PMID 30206821, PMID 30243803, PMID 30521533, PMID 31139483, PMID 31802967, PMID 32411431, PMID 32427087, PMID 38449081, PMID 38770818, PMID 39963952, PMID 41665872, PMID 11128341, PMID 11351356, PMID 11463434, PMID 12893742, PMID 16123474, PMID 16163360, PMID 16291063, PMID 16291066, PMID 16316360, PMID 17425550, PMID 17977931, PMID 18496508, PMID 18784623, PMID 18796160, PMID 19366972, PMID 19526210, PMID 19577022, PMID 19637208, PMID 20393508, PMID 20413516, PMID 20416952, PMID 20465525, PMID 20668482, PMID 20966122, PMID 21146749, PMID 21346609, PMID 21372298, PMID 21622669, PMID 21719618, PMID 21775755, PMID 21898720, PMID 22080911, PMID 22169682, PMID 22176513, PMID 22250209

NIH funding

2014 (2), 2015 (2), R01NS057594 (2), 2005 (1), 2008 (1), 2009 (1), 2019 (1), 2023 (1)